Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2005 02:12 ET | Source: Crucell N.V.

Galapagos NV & ASINEX Ltd. Initiate Drug Discovery Collaboration in Bone and Joint Diseases

MECHELEN, Belgium and MOSCOW, May 12, 2005 (PRIMEZONE) -- Galapagos NV, a genomics-based drug discovery company and ASINEX Ltd, a worldwide leader in lead generation and optimization announce that...
April 29, 2005 02:09 ET | Source: Crucell N.V.

Crucell N.V.: Single-Shot Outbreak Vaccine Provides Full Protection Against Ebola According to Results of New Animal Studies

LEIDEN, Netherlands, April 29, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today reported new results from its Ebola vaccine studies. The studies,...
April 27, 2005 02:06 ET | Source: Crucell N.V.

Crucell to Present at Rodman & Renshaw 2nd Annual Global Healthcare Conference, May 4

LEIDEN, Netherlands, April 27, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced that its Chief Financial Officer, Leonard Kruimer CPA, will...
April 18, 2005 08:38 ET | Source: Crucell N.V.

Crucell Announces First Quarter 2005 Results

-- Agreements signed for further development and commercialization of Ebola and Marburg vaccines. -- Strong US and European endorsement of PER.C6(R)-based vaccine technology. -- Five new...
April 14, 2005 02:17 ET | Source: Crucell N.V.

Crucell and NIH Sign 21.4 Million Ebola Vaccine Manufacturing Contract

LEIDEN, Netherlands, April 14, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has signed a manufacturing contract with the Vaccine...
April 14, 2005 01:31 ET | Source: Crucell N.V.

Cystic Fibrosis Foundation Therapeutics and Galapagos Initiate

BETHESEDA, Maryland and LEIDEN, Netherlands, April 14, 2005 (PRIMEZONE) -- Galapagos and Cystic Fibrosis Foundation Therapeutics Sign Euro 1.3 million* Agreement. Cystic Fibrosis Foundation...
April 12, 2005 05:07 ET | Source: Crucell N.V.

Galapagos Appoints Andre Hoekema as Managing Director Galadeno

LEIDEN, Netherlands, April 12, 2005 (PRIMEZONE) -- Galapagos, a genomics-based drug discovery company, has appointed Dr. Andre Hoekema as Managing Director of Galadeno, Galapagos' services unit....
April 05, 2005 08:07 ET | Source: Crucell N.V.

Crucell to Release First Quarter 2005 Earnings on Monday, April 18

LEIDEN, Netherlands, April 05, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced that it will release its financial results for the first...
April 05, 2005 02:07 ET | Source: Crucell N.V.

Crucell Receives U.S. Patent Covering its STAR Technology

LEIDEN, Netherlands, April 5, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has been granted a patent by the United States Patent...
April 01, 2005 10:44 ET | Source: Crucell N.V.

Crucell's Cell-Culture Technology to Be Part of Major U.S. Government Influenza Pandemic Vaccine Program

LEIDEN, Netherlands, April 1, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that its partner sanofi pasteur, the vaccines business of the...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right